← Leaderboards
Benjamin M. Ellingson
University Of California Los Angeles
$5,183,626
Attributed
$8,849,937
Total exposure
9
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2012–25$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,849,937 · 9
By mechanism
R01$6,175,696 · 3
P50$1,600,764 · 3
R21$724,452 · 2
T32$349,025 · 1
Top collaborators
- David A. Nathanson7 shared
- Langston Tyler Holly5 shared
- Timothy Cloughesy4 shared
- Robert M Prins1 shared
Most similar at University Of California Los Angeles
Same institution · by research overlap
- David A. Nathanson$10,691,258
- Sherin U. Devaskar$31,339,941
- David Sigmund Liebeskind$10,675,130
- Paul M Thompson$55,589,208
- Johannes Czernin$5,995,082
Others in their field
Top investigators on “Response”
- Lawrence Corey · Fred Hutchinson Cancer Center$677,505,141
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$532,027,174
- Barton F Haynes · Duke University$497,761,007
- Jeffrey P Krischer · University Of South Florida$397,532,270
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
Research focus
ResponseMeasurementMagnetic Resonance ImagingDiffusion Magnetic Resonance ImagingTumorGlioblastomaBiological MarkersDiffusionImageComplexMetabolicImaging TechniquesPositron-Emission TomographyLinkEffective TherapyNeuroimagingClinical TrialsAminesAnatomyAngiogenesis InhibitorsGliomaNeoplastic CellBrainIn Vivo
Grant awards (27)
Role of decorin and diffusion MRI in anti-VEGF efficacy for recurrent glioblastoma$607,842
R01 · FY2025 · CA · contact PI
Quantitative molecular MR-PET imaging of glycolysis in glioblastoma$594,570
R01 · FY2025 · CA · contact PI
Neuro-Oncology Translational Research Training Program (NOTR-TP)$349,025
T32 · FY2025 · CA
Core 2: Neuro-Imaging Core (NIC)$212,987
P50 · FY2025 · CA · contact PI
Core 2: Neuro-Imaging Core (NIC)$8,612
P50 · FY2025 · CA · contact PI
Quantitative molecular MR-PET imaging of glycolysis in glioblastoma$588,416
R01 · FY2024 · CA · contact PI
Role of decorin and diffusion MRI in anti-VEGF efficacy for recurrent glioblastoma$587,142
R01 · FY2024 · CA · contact PI
Core 2: Neuro-Imaging Core (NIC)$209,647
P50 · FY2024 · CA · contact PI
Quantitative molecular MR-PET imaging of glycolysis in glioblastoma$619,045
R01 · FY2023 · CA · contact PI
Role of decorin and diffusion MRI in anti-VEGF efficacy for recurrent glioblastoma$605,684
R01 · FY2023 · CA · contact PI
Core 2: Neuro-Imaging Core (NIC)$191,714
P50 · FY2023 · CA · contact PI
Role of decorin and diffusion MRI in anti-VEGF efficacy for recurrent glioblastoma$623,037
R01 · FY2022 · CA · contact PI
Spinal and Cerebral biomarkers for measuring disease progression and prognosis in chronic spinal cord injury$388,139
R01 · FY2022 · NS
Core 2: Neuro-Imaging Core (NIC)$188,594
P50 · FY2022 · CA · contact PI
Spinal and Cerebral biomarkers for measuring disease progression and prognosis in chronic spinal cord injury$388,139
R01 · FY2021 · NS
Core 2: Neuro-Imaging Core$153,000
P50 · FY2021 · CA · contact PI
Spinal and Cerebral biomarkers for measuring disease progression and prognosis in chronic spinal cord injury$388,139
R01 · FY2020 · NS
Core 2: Neuro-Imaging Core$156,349
P50 · FY2020 · CA · contact PI
Spinal and Cerebral biomarkers for measuring disease progression and prognosis in chronic spinal cord injury$388,139
R01 · FY2019 · NS
Metabolic MRI for quantifying aerobic glycolysis and immune function in gliomas$163,850
R21 · FY2019 · CA · contact PI
Core 2: Neuro-Imaging Core$153,002
P50 · FY2019 · CA · contact PI
Spinal and Cerebral biomarkers for measuring disease progression and prognosis in chronic spinal cord injury$397,404
R01 · FY2018 · NS
Metabolic MRI for quantifying aerobic glycolysis and immune function in gliomas$202,204
R21 · FY2018 · CA · contact PI
Core 2: Neuro-Imaging Core$167,933
P50 · FY2018 · CA · contact PI
Core 2: Neuro-Imaging Core$158,926
P50 · FY2017 · CA · contact PI
Cell invasion, motility, and proliferation level estimate maps in gliomas$157,427
R21 · FY2013 · CA · contact PI
Cell invasion, motility, and proliferation level estimate maps in gliomas$200,971
R21 · FY2012 · CA · contact PI